Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 251 - 300 out of 98,450

Document Document Title
WO/2017/082761A1
The invention relates to agricultural microbiology and particularly to Paenibacillus mucilaginosus strain Pm 2906 (VKPM deposit number B-12259), and to a fertiliser based thereon. A fertiliser for crop cultivation is obtained by the step...  
WO/2017/079936A1
Provided is a system expressing a heterologous gene, containing a Listeria bacteria and a recombinant expression vector. Also provided is a method for expressing a target gene containing the system, a biological agent and a method for pr...  
WO/2017/083858A3
The present disclosure relates to a novel method, expression vectors, and host cells for producing nicotinamide riboside by regulating the pathways that lead to the production of nicotinamide riboside.  
WO/2017/083351A1
Non-naturally occurring microorganisms are provided that produce taurine and/or taurine precursors, e.g., hypotaurine, sulfoacetaldehyde, or cysteate, utilizing exogenously added enzyme activities. Methods of producing taurine and/or tau...  
WO/2017/080111A1
Provided is a genetically-engineered strain for producing cadaverine. A lysine decarboxylase promoter 1dcCp is replaced as an environmental/nutritional factor-control promoter, and a signal peptide is expressed at the same time; the lysi...  
WO/2017/083858A2
The present disclosure relates to a novel method, expression vectors, and host cells for producing nicotinamide riboside by regulating the pathways that lead to the production of nicotinamide riboside.  
WO/2017/079872A1
Provided are microorganisms genetically modified to overexpress porin polypeptides to enhance the production of lysine and lysine derivatives by the microorganism. Also provided are methods of generating such microorganism, and methods o...  
WO/2017/082294A1
Provided, as substances that exhibit an excellent proliferation promoting effect on stem cells, are bFGF fragment peptides, FGF receptor-binding peptides, peptides comprising a bFGF heparin-binding region, bFGF-binding protein fragment p...  
WO/2017/080987A2
The present invention relates to a method for improving biomass production and/or growth rate of a microorganism in a fermentation process, said method comprises the steps of: (i) providing one or more microorganism; (ii) providing a fer...  
WO/2017/083493A1
This document describes biochemical pathways for biosynthesizing a 3-oxo-7-hydroxyheptanoyl-CoA intermediate using a β-ketothiolase, and enzymatically converting 3-oxo-7-hydroxyheptanoyl-CoA to 7-hydroxyheptanoic acid. - 7-hydroxyheptan...  
WO/2017/079725A1
Modified peptides based on C-terminal PDZ binding domains of PTEN and PHLPP, or PDK1 interacting fragment of PKN2 are described as are methods of using the modified peptides for blocking the activity of PTEN, PHLPP and PKN2 and treating ...  
WO/2017/077104A1
Disclosed are methods for identifying microbes that associate with other microbes, and possess new or improved characteristics. Also disclosed are microbes isolated using the methods. Also disclosed are methods for using the microbes.  
WO/2017/078137A1
The present invention provides: a method for producing an acyl glucuronide of a target compound having a carboxyl group, the method characterized by comprising step A for culturing a microorganism having acyl glucuronide transformation a...  
WO/2017/078029A1
The purpose of the present invention is to provide: a myosatellite cell-culturing material, by means of which cells are proliferated while remaining undifferentiated; and a culturing method using the same. The present invention pertains ...  
WO/2017/079682A1
In some aspects, the invention relates to selectively permeable cell culture vessel storage containers and their methods of use. In some embodiments, the containers comprise a gas-permeable membrane that is selectively impermeable to wat...  
WO/2017/079308A3
The present invention provides mutant microorganism that have higher lipid productivity than the wild type microorganisms from which they are derived while producing biomass at levels that are at least 45% of wild type biomass productivi...  
WO/2017/078156A1
The purpose of the present invention is to provide a yeast that produces ethanol from xylose and a method for producing ethanol from xylose with the use of the yeast. The present invention relates to: a transformed yeast prepared by expr...  
WO/2017/077320A1
The present invention relates to genetically modified microorganisms comprising one or more heterologous nucleic acid molecules together encoding at least three different proteins, each protein comprising an enzymatic domain and a bacter...  
WO/2017/077924A1
The present invention addresses the problem of providing a novel FAD-GDH having high practicality. Provided is a glucose dehydrogenase provided with the features below. (1) Effect: the present invention catalyzes a reaction for oxidizing...  
WO/2017/079036A1
This disclosed subject matter concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran p...  
WO/2017/079450A1
Disclosed are methods and compositions for the prevention and treatment of food allergy. In particular, described herein are microbial consortia, including minimal microbial consortia, that can prevent and/or cure food allergy. In certai...  
WO/2017/073533A1
The present invention addresses the problem of providing a means for increasing the efficiency of recovering rare cells in a cell suspension by suppressing adsorption of the cells to the experimental equipment without inhibiting adsorpti...  
WO/2017/071664A1
Provided is a soluble pyrroloquinoline quinone dependent glucose dehydrogenase (PQQ-sGDH) mutant, wherein the amino acid positions thereof correspond to a wild type PQQ-sGDH sequence of Acinetobacter calcoaceticus as shown in SEQ ID NO: ...  
WO/2017/073786A1
Provided are: a glucose dehydrogenase having modified electron transfer properties; and a glucose measurement method and a measurement kit that use said glucose dehydrogenase having modified electron transfer properties. The glucose dehy...  
WO/2017/075485A1
The present invention provides recombinant bacterial cells comprising gene sequence encoding one or more trimethylamine catabolism enzyme(s). The recombinant bacterial cells optionally comprise gene sequence encoding one or more TMA and/...  
WO/2017/072296A1
The present invention relates generally to growth of bacteria. More specifically the invention relates to a method for oxidative environment adaptation of anaerobic microorganisms and their use in developing new probiotics. In particular...  
WO/2017/075023A1
The present disclosure provides agricultural compositions and methods of using these compositions to increase plant growth, pathogen resistance and drought tolerance. The agricultural compositions disclosed herein comprise mixtures of mu...  
WO/2017/071346A1
Applications of bacteroides fragilis in resistance against aquacultural pathogenic bacteria, comprising applications of the bacteroides fragilis in the preparation of antibacterial medicines for the aquacultural pathogenic bacteria, and ...  
WO/2017/072278A1
The present invention relates generally to medicine. More specifically the invention relates to the use of synergistic probiotic bacteria as intervention for health. In particular, the present invention provides a strain of Faecalibacter...  
WO/2017/074952A1
Biofilms are provided which are capable of regulating their own thickness, reducing contamination and preventing biofouling. Constructs are introduced into bacteria that comprise nucleic acid molecules encoding an autoinducer synthase po...  
WO/2017/073600A1
The present invention is a method for designing mRNA which can be identified with a high degree of accuracy while the cell is still alive. The method is for designing mRNA comprising at least two miRNA response elements, wherein the mRNA...  
WO/2017/073752A1
The present invention addresses the problem of providing a method for producing dried microbial cells with a high viable cell survival rate after long-term storage at a high temperature. Provided is a method for producing dried microbial...  
WO/2017/073640A1
Provided is a transformed cell having improved C4-dicarboxylic acid production capacity. The transformed cell comprises a foreign polynucleotide that codes a polypeptide including the amino acid sequence represented by SEQ. ID 2, the ami...  
WO/2017/074037A1
The present invention relates to: a novel Bacillus amyloliquefaciens strain; a method for preparing a fermented cereal product by using the strain; a fermented cereal product prepared using the strain; and a composition for thrombolysis,...  
WO/2017/073701A3
A method for producing an objective substance, i.e. an aromatic aldehyde such as vanillin, is provided. An objective substance is produced from a carbon source or a precursor of the objective substance by using a coryneform bacterium hav...  
WO/2017/072748A1
A method for producing lactic acid comprises the steps of culturing in a culture medium comprising concentrated whey permeate or delactosed whey permeate as a substrate a bioconversion competent Bacillus bacterial strain capable of conve...  
WO/2017/073717A1
The present invention provides a method for producing a steviol glycoside and/or steviol, said method including a step in which a steviol glycoside having at least one unbranched β1,2-glycosidic bond is reacted with the glycosidase AOBG...  
WO/2017/075195A1
The present disclosure is generally related to modified Gram positive bacterial cells producing increased amounts of one or more protein(s) of interest and modified Gram positive bacterial cells having increased genetic competency. Thus,...  
WO/2017/071006A1
Provided is a Corynebacterium crenatum for recombinant expression of an arginine deiminase, wherein same is a genetically engineered bacterium obtained by means of arginine deiminase genes from Lactobacillus brevis and being connected to...  
WO/2017/074566A1
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of treating or preventing autoimmune disorders, inhibiting inflammatory mechanisms in the gut, and/or tightening gut mucosal barrier function are disclosed.  
WO/2017/073550A1
Provided are a composition, food and drink that exert, through oral ingestion of a lactic acid bacterium, a culture product thereof, a processed product thereof or a composition comprising the same, an effect of enhancing an immune respo...  
WO/2017/070200A1
A method for enhancing yeast growth for bioproduct production is described. A method for fermentative bioproduct production also is provided. A nutrient composition used in the methods also is described. A liquid mixture containing the n...  
WO/2017/068385A1
The present invention relates to a genetically modified microorganism for the fermentative conversion of levulinic acid into propionyl-CoA and acetyl-CoA, and to a fermentation process for performing said conversion.  
WO/2017/069267A1
The present invention pertains to recombinant eukaryotic micro-organisms into which genes that encode acyl-CoA dehydroquinases have been introduced, and a method for producing methacrylic acid esters such as MMA and MMA-CoA, and precurso...  
WO/2017/068972A1
The present invention provides a cell isolation device and cell isolation method capable of selecting cells having high antibody-production ability, from a candidate cell group by using a simple process but causing less damage to the cel...  
WO/2017/069158A1
The purpose of the present invention is to provide a polypeptide that has a high binding capacity to immunoglobulin kappa chains and excellent alkali stability by modifying an amino acid sequence in immunoglobulin-binding domains of prot...  
WO/2017/070404A2
Mutant photosynthetic algae having increased biomass productivity are provided. The mutants have attenuated expression of violaxanthin chlorophyll a binding proteins (VCP) or fucoxanthin chlorophyll a/c binding proteins (FCP), reduced ch...  
WO/2017/067089A1
Provided is a neovison vison klebsiella peneumoniae strain which is named as a WMOK strain with the preservation number of CGMCC NO.11222. The strain is K2 type, is Gram-negative (G-), facultatively anaerobic, atrichous and asporous, and...  
WO/2017/069479A1
The present invention relates to a method for manufacturing an organic fertilizer prepared using antagonistic microorganisms, fermentative microorganisms, synthetic microorganisms, and organic raw materials, and to an organic fertilizer ...  
WO/2017/069781A1
A cell lysis workflow involving a cell suspension that is passed through a filter in a first flow direction from a first side of the filter toward a second side thereof. The filter captures a plurality of cells on the first side. A lysis...  

Matches 251 - 300 out of 98,450